After a day of guided visit through the labs of the Instituto Nacional de Saúde (INS) the on 23rd October, the inaugural consortium meeting of the Sub-Saharan SeqNET project convened on October 24th, 2023, at 10:00 AM Maputo time, in the main conference hall of Hotel Cardoso, Maputo, Mozambique. The…
Context Lung diseases are an increasing cause of morbidity and mortality worldwide. Every year, approximately 10 million new cases of tuberculosis (TB) are recorded, resulting in approx.1.5 million deaths. (Multi-) drug-resistant strains further complicate global TB control and challenge the WHO’s goal to end the TB epidemic by 2030. Moreover,…
Short Description In order to achieve the World Health Organization’s End TB Strategy goals, in addition to scientific innovations, there is a need for countries and organisations to work together at national and international level. With an increasingly mobile world population, improved tuberculosis care and prevention among migrants needs to…
Short Description Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) represent an increasing threat for global tuberculosis (TB) control. Successful control of M/XDR-TB requires efficient drug susceptibility testing (DST) as basis for designing effective therapy regimens. However, e.g. due to inadequate infrastructure, DST is often missing or delayed in countries…
Description The main goal of the COVIDSeq_NET project is to determine the genetic diversity of SARS-CoV-2 variants since the beginning of the outbreak in Mozambique. As part of our long-term collaboration between the Instituto Nacional de Saúde (INS) and the Research Center Borstel, Leibniz Lung Center (RCB), we will perform…
In the first half of November 2021 four members of the technology implementation team of Research Center Borstel – Leibniz Lung Center (RCB) visited the National Institute of Health (INS) in Maputo, Mozambique to hold a joint training in “Next Generation Sequencing for prediction of drug resistance in clinical M.
Eswatini will now be able to detect drug resistant TB and COVID-19 variants after the National Referral Laboratory (NRL) introduced genomic sequencing technology. The Director of Health Services, Dr. Vusi Magagula, commissioned the launch of the TB sequencing laboratory in the presence of the German partner Prof. Dr. Stefan Niemann…
In the framework of the GHPP project SeqMDRTB_NET the technology implementation team of Research Center Borstel – Leibniz Lung Center (RCB) visited the National Institute of Health (INS) in Maputo, Mozambique in November 2021. INS has potential to set up the new technology of targeted next generation sequencing (tgNGS), which…